Koninklijke Philips
Koninklijke Philips N.V. is a Dutch health technology company that develops and manufactures medical imaging systems, patient monitoring devices, and personal health products. The company structures its global business operations across three main reporting segments, comprising Diagnosis & Treatment, Connected Care, and Personal Health. Primary revenue drivers include the manufacturing and sale of magnetic resonance imaging systems, computed tomography scanners, image-guided therapy equipment, patient ventilators, and electric toothbrushes. Key end markets include public and private hospitals, diagnostic centers, sleep clinics, home healthcare providers, and retail consumers worldwide. The firm integrates medical hardware, artificial intelligence algorithms, and clinical informatics software to improve diagnostic accuracy and health workflow efficiency in clinical settings. Koninklijke Philips holds a leading global market position in image-guided therapy, patient monitoring, and clinical informatics hardware. The enterprise is headquartered in Amsterdam, Netherlands, and its common shares are traded on Euronext Amsterdam and the New York Stock Exchange under ticker PHIA.
56 of the funds FundTelligence covers report a position in Koninklijke Philips.
- Sector
- Health Care
- Country
- Netherlands
- Funds holding it
- 56
Funds holding Koninklijke Philips
- UBS Sustainable Health Transformation Equity Fund — UBS · 3.9 % (largest positions only, September 2026)
- Nordea European Cross Credit ESG Fund — Nordea Funds · 1.67 % (full portfolio disclosed, July 2026)
- Danske Invest European Corporate Sustainable Bond — Danske Invest · 1.49 % (full portfolio disclosed, September 2026)
- Nordea European Corporate Sustainable Labelled Bond — Nordea Funds · 1.41 % (full portfolio disclosed, September 2026)
- Sparinvest European Value — Sparinvest · 1.3 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI Europe Health Care Sector UCITS ETF — BlackRock · 1.21 % (full portfolio disclosed, October 2026)
- Sparinvest Ethical Global Value — Sparinvest · 1.1 % (full portfolio disclosed, September 2026)
- Schroder ISF EURO Equity — Schroders · 1.08 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 56 funds holding it.